Auxilium has provided its contractually obligated six-month notice of termination which, absent an agreement between Auxilium and VIVUS for an earlier date, will result in the termination of
This study aims to include CD19-positive Acute Lymphoblastic Leukemia (ALL) patients. Other eligibility criteria to enter clinical trials will be assessed by the investigators. "It has been a
The acquisition provides Agenus the ability to accelerate the development of new cancer vaccines and other single agent immuno-oncology approaches, as well as combination therapies. "PhosImmune’s groundbreaking neoantigen
Dr. Carmelo A. Milano, the Professor and Surgical Director for Heart Transplant and LVAD Program, Dr. Mani Daneshmand, Dr. Roberto Manson and Dr. Dawn E. Bowles from Duke
Patients suffering from these severe gout indications accumulate uric acid deposits in joints and tissues, which can cause debilitating pain and damage to joints and organs. SEL-212, the
The ongoing phase-2 clinical trial investigates the safety and efficacy of ACP-01, which uses angiogenic progenitor cells to combat the life-threatening complications of CLI. These proprietary cells are
Forge Therapeutics CEO Zachary Zimmerman said: "We are pleased to obtain exclusive worldwide rights to this intellectual property, which adds to our expanding and dominant patent portfolio protecting
The agreement was executed based on a series of studies using validated animal models of CIPN exposed to unique cannabinoid-based therapies conducted in the lab of Dr. Kenneth
The amendment includes a change in primary endpoint to overall survival to enable a potential registration opportunity for MM-121. Merrimack president and CEO Robert Mulroy said: "We believe
Vanda president and CEO Mihael Polymeropoulos said: "The MAA validation demonstrates Vanda’s commitment to offer another option to the healthcare community to treat a severe, disabling mental disorder.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.